IP Library Granted Patent US 8,383,371
Granted Patent B2
US 8,383,371 · App. 12/958,318 · Granted Feb 26, 2013

Nucleic acid construct containing a nucleic acid derived from the genome of hepatitis C virus (HCV) of genotype 2a, and a cell having such nucleic acid construct introduced therein

Inventors: Takaji Wakita (Tokyo, JP); Takanobu Kato (Nagoya, JP); Tomoko Date (Kawasaki, JP)
Assignees: Toray Industries, Inc.; Tokyo Metropolitan Institute of Medical Science; Ralf Bartenschlager
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,383,371
App. No.
12/958,318
Granted
Feb 26, 2013
Kind
B2
Abstract

The present invention relates to a replicon RNA comprising a nucleotide sequence at least containing the 5′ untranslated region, the nucleotide sequence encoding NS3 protein, NS4A protein, NS4B protein, NS5A protein and NS5B protein, and the 3′ untranslated region on the genomic RNA of hepatitis C virus of genotype 2a.

Claims (3)

1. A replicon RNA, comprising a nucleotide sequence containing at least the 5′ untranslated region, the nucleotide sequence encoding NS3 protein, NS4A protein, NS4B protein, NS5A protein and NS5B protein and the 3′ untranslated region of the genomic RNA of hepatitis C virus of genotype 2a strain JFH-1, and further containing a nucleotide sequence encoding a viral protein from the genomic RNA of an HCV strain or HCV genotype other than JFH-1.

2. The replicon of claim 1 , said replicon further containing either one or both of a selection marker gene and/or a reporter gene.

3. The replicon of claim 1 , wherein said HCV strain or HCV genotype other than JFH-1 is HCV-1, HCV-H, HC-J1, HCT-18, DK-7, US11, S14, HCT23, HCV-Th, DR1, DR4, HCT27, S18, SW1, DK9, H90, TD-6E1, 59, HCV-BK, T10, DK1, HC-J4, HCV-J, HK3, HK8, HK5, HCV-G3, IND5, IND8, P10, D1, D3, SW2, T3, S45, SA10, US6, HCV-JK1, HCV-JK4, HCV-JK3, HCV-JK2, HCV-JT, HC-J2, HCV-T, HK4, HC-G9, Z1, T4, T9, US10 HC-J5, T2, HC-J7, DK11, SW3, DK8, T8, HC-J8, S83, HK2, HC-J6, HC-J8, BEBE1, HCV-J6, HCV-J8, HD10-2, BR36-9, S52, S54, 82, BR33-1, HK10, DK12, HCV-TR, BA-1, BA-2, DK13, Z1, Z4, Z6, Z7, HK2, SA1, SA4, SA5, SA7, SA13, SA6, NZL1, SA30, EG-13, HCV-K3a/650, ED43, EUH1480, EUHK2, Th580, VN235, VN405, VN004, JK049, JK046, JCH-1, JCH-2, JCH-3, JCH-4, JCH-5, JCH-6, J6CF, or H77.

Assignments (1)
CHANGE OF NAME Recorded Sep 20, 2011
From: TOKYO METROPOLITAN ORGANIZATION FOR MEDICAL RESEARCH
To: TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE
Reel/Frame 026931/0980 →
Priority Claims (2)
JP 2003-148242 · May 26, 2003 · national
JP 2003-329115 · Sep 19, 2003 · national
Continuity (2)
Division 10558155
Related Publication 20110092688A1 · Apr 21, 2011